Chemomab Therapeutics Ltd. Holds Annual Shareholder Meeting
Ticker: CMMB · Form: 6-K · Filed: Jul 1, 2025 · CIK: 1534248
| Field | Detail |
|---|---|
| Company | Chemomab Therapeutics LTD. (CMMB) |
| Form Type | 6-K |
| Filed Date | Jul 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, corporate-governance
TL;DR
Chemomab held its shareholder meeting July 1st, nothing major reported.
AI Summary
Chemomab Therapeutics Ltd. held its annual general shareholders meeting on July 1, 2025. The company, formerly known as Anchiano Therapeutics Ltd. and BioCancell Ltd., is a pharmaceutical preparations company based in Tel Aviv, Israel. This 6-K filing serves to report the results of this meeting.
Why It Matters
This filing confirms the completion of the annual general meeting, a standard corporate governance event for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine 6-K filing reporting on a shareholder meeting, with no new financial or operational information disclosed.
Key Players & Entities
- Chemomab Therapeutics Ltd. (company) — Registrant
- July 1, 2025 (date) — Date of annual general shareholders meeting
- Anchiano Therapeutics Ltd. (company) — Former company name
- BioCancell Ltd. (company) — Former company name
- Meitar | Law Offices (company) — Location of meeting
FAQ
What is the purpose of this 6-K filing?
This 6-K filing is to report the results of Chemomab Therapeutics Ltd.'s annual general shareholders meeting held on July 1, 2025.
When was the annual general shareholders meeting held?
The meeting was held on July 1, 2025, at 4:30 p.m. (Israel time).
Where was the annual general shareholders meeting held?
The meeting was held at Meitar | Law Offices, located at 16 Abba Hillel Road.
What are the former names of Chemomab Therapeutics Ltd.?
Chemomab Therapeutics Ltd. was formerly known as Anchiano Therapeutics Ltd. and BioCancell Ltd.
Does Chemomab Therapeutics Ltd. file annual reports under Form 20-F or 40-F?
Chemomab Therapeutics Ltd. files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 1, 2025 regarding Chemomab Therapeutics Ltd. (CMMB).